TRACON Pharmaceuticals In... (TCON)
0.03
-0.00 (-6.83%)
At close: Feb 28, 2025, 3:00 PM
1.08
3254.04%
After-hours: Jun 27, 2024, 07:53 PM EDT
TRACON Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 12.04M | n/a | 346K | n/a | n/a | 3M | 8.76M | 3.45M | 7.9M | 3.6M | n/a | n/a |
| Cost of Revenue | 14K | 16K | 14K | 12K | 22K | 30.46M | 19.36M | 15.24M | 20.43M | 4.85M | 3.98M | 2.09M |
| Gross Profit | 12.03M | -16K | 332K | -12K | -22K | -27.46M | -10.6M | -11.79M | -12.53M | -1.25M | -3.98M | -2.09M |
| Operating Income | -6.9M | -27.89M | -28.35M | -16.22M | -22.3M | -34.74M | -18.21M | -25.98M | -23.47M | -6.18M | -7.56M | -5.23M |
| Interest Income | n/a | 994K | 318K | 545K | 386K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -3.59M | -29.14M | -28.67M | -16.77M | -22.67M | -34.96M | -19.1M | -27.01M | -24.41M | -6.81M | -7.71M | -4.93M |
| Net Income | -3.59M | -29.31M | -28.73M | -17.33M | -22.66M | -34.96M | -19.1M | -27.01M | -24.41M | -6.81M | -7.71M | -4.93M |
| Selling & General & Admin | 6.67M | 14.01M | 17.55M | 8.03M | 7.77M | 7.28M | 7.61M | 7.86M | 5.69M | 2.13M | 1.48M | 1.45M |
| Research & Development | 12.28M | 13.89M | 11.15M | 8.2M | 14.53M | 30.46M | 19.36M | 21.57M | 25.68M | 7.65M | 6.08M | 3.78M |
| Other Expenses | n/a | -1.24M | -320K | -7K | -378K | 12K | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 18.93M | 27.89M | 28.69M | 16.22M | 22.3M | 37.74M | 26.96M | 29.43M | 31.37M | 9.78M | 7.56M | 5.23M |
| Interest Expense | 7.3M | 994K | 318K | 545K | 386K | 231K | 886K | 1.12M | 923K | 667K | 30K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 18.94M | 27.89M | 28.69M | 16.22M | 22.3M | 37.74M | 26.96M | 29.43M | 31.37M | 9.78M | 7.56M | 5.23M |
| Income Tax | n/a | 177K | 59K | 551K | -16K | 12K | 845K | 938K | 892K | 615K | 30K | n/a |
| Shares Outstanding (Basic) | 1.63M | 1.05M | 862.63K | 448.53K | 151.72K | 134.73K | 84.03K | 63.39K | 55.58K | 59.89K | 2.45K | 161.49K |
| Shares Outstanding (Diluted) | 1.64M | 1.05M | 862.63K | 449.21K | 151.72K | 134.73K | 84.03K | 63.39K | 55.58K | 59.89K | 2.45K | 161.49K |
| EPS (Basic) | -2.2 | -28.02 | -33.3 | -38.63 | -149.35 | -259.47 | -227.33 | -426.06 | -439.2 | -113.7 | -3.14K | -30.52 |
| EPS (Diluted) | -2.19 | -28.02 | -33.3 | -38.57 | -149.35 | -259.47 | -227.33 | -426.06 | -439.2 | -113.7 | -3.14K | -30.52 |
| EBITDA | -6.88M | -27.89M | -28.33M | -16.22M | -22.27M | -34.71M | -18.17M | -25.8M | -23.42M | -6.16M | -7.55M | -5.22M |
| Depreciation & Amortization | 14K | 16K | 14K | 12K | 22K | 28K | 48K | 94K | 51K | 15K | 7K | 6K |